PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Clinical trial NCT05341193 · UNKNOWN
Trial details
- NCT number
- NCT05341193
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-30
- Primary completion
- 2023-04-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.